Is it time for Point of Care Companion Diagnostics?
Time: 12:50 pm
day: Day 1 Track A AM
Details:
Diagnostic testing beyond the central laboratory has been available for decades but was not widely used or accepted by clinical providers until the COVID pandemic when simple molecular and antigen tests became standard of care. Given the availability, accuracy, and acceptance of these tests, new multiplex Point of Care (POC) devices are under development beginning with respiratory pathogens such as influenza, RSV and adenovirus. We will explore the feasibility and clinical value of POC testing as a companion Diagnostic (CDx) strategy. Our presentation will focus on the following:
- Technical feasibility
- Possible formats
- Example applications
- Future Home Use/Over the Counter applications
- Regulatory strategies
- Community Applications
